baber/WOPTO huggingface dataset:
Patent JP-4260889-B2 (JP)
IPC: A61K33/243
Filed: 1997-10-02
Granted: 2009-04-30
Abstract: Methods of preventing or reducing hearing or balance loss, damage to ear cells, weight loss, gastrointestinal toxicity, neurotoxicity, alopecia, and prolonging survival in patients undergoing treatment with therapeutically effective amounts of platinum-containing chemotherapeutic agents such as cisplatin are provided. These methods comprise administering an effective amount of a methionine protective agent, such as D-methionine, prior to, simultaneously with, or subsequently to administration of the platinum-containing chemotherapeutic agent. Combinations of these time periods can also be employed.
Patent JP-3203359-B2 (JP)
IPC: A23L35/00
Filed: 1995-02-06
Granted: 2001-08-27
Abstract: PCT No. PCT/SE95/00117 Sec. 371 Date Jul. 15, 1996 Sec. 102(e) Date Jul. 15, 1996 PCT Filed Feb. 6, 1995 PCT Pub. No. WO95/20945 PCT Pub. Date Aug. 10, 1995The invention relates to a lipophilic carrier preparation having a continuous lipid phase, comprising a polar lipid material in combination with a non-polar lipid, and optionally a polar solvent, wherein the polar lipid material is a galacto-lipid material. The invention also relates to the use of said lipophilic carrier preparation as a carrier for an active substance in a pharmaceutical composition, but also in nutritional, cosmetical and food products, as well as to a pharmaceutical composition. The invention relates to a lipophilic carrier preparation having a continuous lipid phase, comprising a polar lipid material in combination with a non-polar lipid, and optionally a polar solvent, wherein the polar lipid material is a galactolipid material. The invention also relates to the use of said lipophilic carrier preparation as a carrier for an active substance in a pharmaceutical composition, but also in nutritional, cosmetic and food products, as well as to a pharmaceutical composition.
Patent JP-4318754-B2 (JP)
IPC: B29C45/03
Filed: 1997-10-28
Granted: 2009-08-26
Abstract: A container having a resealable closure thereon is produced by a method including the steps of providing a closure having a spout and a flange and a stem projecting therefrom, placing the closure about an access area of the container and welding the closure to the container body thereby bonding at least one portion of a hinge to the spout. The closure stem defines an aperture and the cap has a lid and skirt projecting therefrom. The skirt is configured to prevent interference during pouring of the contents of the container. The hinge assembly connects the cap to the spout and allows for reclosable opening of the cap from the spout while maintaining the attachment of the cap with the spout. A tamper-evident structure is formed integrally with the cap including a removable portion secured to the closure by a breakable joint. The closure further includes an orienting projection for orienting the closure on the container at a predetermined location and position.
Patent JP-3990449-B2 (JP)
IPC: C07B61/00
Filed: 1996-04-24
Granted: 2007-10-10
Abstract: PCT No. PCT/EP96/01730 Sec. 371 Date Nov. 13, 1997 Sec. 102(e) Date Nov. 13, 1997 PCT Filed Apr. 24, 1996 PCT Pub. No. WO96/36607 PCT Pub. Date Nov. 21, 1996A process has been found for preparing pyridine-2,6-diamines, i.e., 2,6-diaminopyridine (DAP) and derivative compounds in which one of the amino groups is a substituted amine (secondary or tertiary). According to this process, 3-hydroxy pentane 1,5-dinitrile (3-hydroxyglutaronitrile) is reacted with an ammonium donor in the form of ammonia, a primary amine such as n-butylamine, or a secondary amine such as piperidine.
Patent JP-4400933-B2 (JP)
IPC: C07C43/295
Filed: 1996-08-27
Granted: 2010-01-20
Abstract: The present invention provides a process for the preparation of a compound of formula   <IMAGE>   wherein R is a straight or branched alkyl group of from one to twelve carbon atoms; M represents hydrogen or a pharmaceutically acceptable cation; and A is selected from optionally substituted carbocyclic phenyl.
Patent JP-4472787-B2 (JP)
IPC: C12N9/24
Filed: 1998-02-26
Granted: 2010-06-02
Abstract: It has been found by a screening assay that XET activity is produced by an overwhelming array of phylogenetically dispersed microorganisms. Accordingly, the present invention relates to a xyloglucan endotransglycosylase preparation which is producible by cultivation of a microorganism expressing an XET.
Patent JP-4108126-B2 (JP)
IPC: C12N15/00
Filed: 1997-04-28
Granted: 2008-06-25
Abstract: The present invention relates to the field of molecular biology and immunology. In particular it relates to vaccines and methods for providing vaccines which elicit immune responses when administered to a mammal, in particular a human. The preferred elicited immune response is a T cell response, elicited by peptide T cell epitopes. These vaccines find their application in many fields ranging from cancer treatments to treatments of prophylaxis of infectious diseases such as Aids. The present invention provides novel methods for selecting the peptide sequences from an intact antigen which will lead to a proper (T cell) immune response upon administration in a suitable vehicle. The epitopes and vaccines are, of course, also part of the present invention.
Patent JP-4184441-B2 (JP)
IPC: C30B33/00
Filed: 1998-03-13
Granted: 2008-11-19
Abstract: This method of removal of irregularities and highly defected regions of the surface of crystals and epitaxial layers of GaN and Ga1-x-yAlxInyN characterized by mechano-chemical polishing on the soft polishing pad under pressure in presence of chemical etching agent of water solution of bases of the total concentration above 0.01N in time longer than 10 seconds after which the agent is replaced by the pure water without interruption of the polishing and polishing by at least 1 minute aid subsequent diminution of the load and stopping of the machine and then the polished GaN crystal or GaAlInN epitaxial layer is removed of the polishing machine and dried in the stream of dry nitrogen.
Patent PL-161614-B2 (PL)
Title: Method of obtaining a mixture of 3,3',5,5'-tetramethyl-4,4'-diphenoquinone and 2,6-dimethyl-p-benzoquinone
Inventor: IGNACZAK MAKSYMILIAN
IPC: C07C27/10
Filed: 1990-06-27
Abstract: A method of obtaining a mixture of 3,3',5,5'-tetramethyl-4,4'-diphenoquinone and 2,6-dimethyl-p-benzoquinone, consisting in oxidization of 2,6-dimethylphenol, characterised in that 2,6-dimethylphenol is dissolved in hydrous-acetonitrile acid solution of perchloric acid and then oxidized by ceric perchlorate in the medium of hydrous solution of perchloric acid, however, the precipitated deposit of 3,3',5,5'-tetramethyl-4-4'-diphenoquinone is filtered off and from the filtrate is extracted 2,6-dimethyl-p-benzoquinone.
Patent AU-2001284691-B2 (AU)
Title: Frequency hopping spread spectrum system with high sensitivity tracking and synchronization for frequency unstable signals
Inventor: HAAS HARRY PRICE
IPC: H04B1/713
Filed: 2001-08-01
Granted: 2005-09-22
Abstract: A wireless spread spectrum communication system for transmitting data includes a plurality of end point transmitters and at least one receiver. The end point transmitters transmit data via a frequency hopped spread spectrum signal where the transmitting signal is sent without the benefit of frequency stabilization. The receiver is responsive to the frequency hopping spread spectrum signals and includes a correlator and a signal processor. The correlator samples at least a first portion of a preamble of the signal and correlates the portion of the preamble with a known preamble pattern to determine a probability of correlation. The signal processor applies a Fast Fourier Transform algorithm to the signal in response to the probability of correlation to track a narrowband frequency of the signal based on at least a second portion of the preamble and to decode data encoded within the signal subsequent to the preamble.
Patent AU-2002231182-B2 (AU)
Title: Surgical articles
Inventor: NEISZ JOHANN J
IPC: A61B17/32
Filed: 2001-12-28
Granted: 2004-11-11
Abstract: Surgical instruments, implantable articles and surgical procedures disclosed for treating medical disorders, particularly incontinence. Improved surgical sling procedures are disclosed. Novel surgical instruments and kits for use in sling procedures are also disclosed. The present invention affords options for surgeons with concomitant advantages to the patient and the healthcare provider.
Patent AU-2002242711-B2 (AU)
Title: Computer system for business applications with alert notification and conditional enforcing
Inventor: BECKER JOACHIM
IPC: G06Q10/00
Filed: 2002-02-27
Granted: 2005-04-21
Abstract: In a computer system (999), peripheral computers (901/902) with business applications (201/202) send alert messages (211/212) to a central computer (900) when a current variable exceeds a reference value. The central computer implements an alert server to notify (301) a target group of multiple users (1, 2, 3) via communication devices (903, 904, 905). The group of users (1, 2, 3) to be notified is determined by subscription or by a role-to-application assignment.   <IMAGE>
Patent AU-2002365415-B2 (AU)
Title: Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof
Inventor: ZHOU RUI
IPC: A23L33/20
Filed: 2002-11-27
Granted: 2008-04-10
Abstract: The present invention discloses methods of making a mixture of theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate, pharmaceutical compositions of the above mixture of theaflavins, diet supplement compositions of the above mixture of theaflavins and methods for using the above mixtures of theaflavin and pharmaceutical compositions thereof to treat or prevent various diseases. The present invention also discloses methods of making theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate, each as a separate compound, pharmaceutical compositions of the above compounds, diet supplement compositions of the above compounds and methods for using the above compounds to treat or prevent various diseases.
Patent AU-2002367032-B2 (AU)
Title: Medicinal aerosol compositions with a functionalized polyethyleneglycol excipient
Inventor: DUAN DANIEL C
IPC: A61K9/00
Filed: 2002-12-20
Granted: 2008-09-25
Abstract: The invention comprises a medicinal aerosol composition comprising a propellant, an excipient comprising a functionalized polyethyleneglycol, and a drug. The invention also comprises particulate medicinal compositions comprising particles with a mean mass aerodynamic diameter of less than about 10 microns that incorporate an excipient comprising a functionalized polyethyleneglycol.
Patent AU-2003205002-B2 (AU)
Title: Polymerization process using mono- and di-functional initiators to prepare fast crystallizing polylactone copolymers
Inventor: BEZWADA RAO S
IPC: A61L31/00
Filed: 2003-06-26
Granted: 2007-07-19
Abstract: The present invention is directed to a process for making an absorbable polylactone copolymer prepared in part from about 2 to about 80 mole percent glycolide, which process utilizes a combination of a monofunctional polymerization initiator and a di-functional polymerization initiator, to achieve rates of crystallization of the copolymer of at least about 2 times faster than the rate of crystallization of a copolymer made by a similar process utilizing either the mono-functional or the di-functional polymerization initiator alone. Absorbable polylactone copolymers prepared by such processes and medical devices containing such copolymers are also disclosed. <IMAGE>
Patent AU-2003252884-B2 (AU)
Title: Closure device for flexible pouches
Inventor: RANI ROBERT G
IPC: A61J1/05
Filed: 2003-10-09
Granted: 2005-09-15
Abstract: The sterile closure device (20) includes a cylinder which extends through a base (22) and a support (26). The cylinder has openings which are blocked by seals. A portion of the cylinder between the seals defines a chamber. An independent claim is also included for a container for a medical fluid.
Patent AU-2003301079-B2 (AU)
Title: Immunoglobulin variants and uses thereof
Inventor: ADAMS CAMELLIA W
IPC: A61K/
Filed: 2003-12-16
Granted: 2011-06-23
Abstract: The invention provides humanized and chimeric anti-CD20 antibodies for treatment of CD20 positive malignancies and autoimmune diseases.
Patent AU-2004237463-B2 (AU)
Title: Communication system
Inventor: MOULSLEY TIMOTHY J
IPC: H04B7/005
Filed: 2004-04-20
Granted: 2008-06-19
Abstract: In a communication system subject to variations in channel quality, transmit power control is used to reduce the variations in received signal quality. If the channel quality degrades to such an extent that a high transmit power would be required to ensure good received signal quality, the transmit power is decreased and is not increased until the channel quality recovers sufficiently to enable an acceptable transmit power level to be used. While the power is at the decreased level, transmission of a data block may continue, or may be suspended, with the data block being truncated if the whole block has not been transmitted by the end of the time period available for transmission of the data block.
Patent AU-2004262465-B2 (AU)
Title: Electric household appliance for steam cooking
Inventor: BARGIACCHI ROGER MANUEL
IPC: A23L5/10
Filed: 2004-07-22
Granted: 2009-01-29
Abstract: An electric household appliance for steam cooking is disclosed, suitable in particular but not exclusively for preparing the so called scrambled eggs, comprising: a basement; a body formed by two separable components, whose lower component comprises the water tank and the resistor for its heating, while the upper component, comprising a spring valve for the steam passage, forms a bearing surface; a container for the food to be cooked, to be placed on the bearing surface; a closure lid with a food mixing device; and an arm, comprising a conduit which allows the diffusion of the steam in the food container and a turbine fan, activated by the steam, which allows the movement of the food mixing device. This appliance allows to steam the food in a quick and healthy way and it is simple, economic and easy to clean.
Patent AU-2004322350-B2 (AU)
Title: Filter unit of air conditioner
Inventor: HUR HYUN
IPC: F24F1/032
Filed: 2004-12-07
Granted: 2009-02-19
Abstract: Disclosed is a filter unit for an air conditioner, which is provided at an indoor unit for the air conditioner so as to purify the air discharged to a room. The filter unit includes a filter for purifying air, a filter case accommodated in the filter and having a filter gate at a side thereof for placing/withdrawing the filter, and a cover for opening/closing the filter gate.
Patent AU-2006200605-B2 (AU)
Title: Control unit having a deployable antenna
Inventor: ALEC GINGGEN
IPC: A61B5/00
Filed: 2006-02-14
Granted: 2011-07-21
Abstract: A control unit for an implantable medical device includes a housing and electronics within the housing. The electronics control an RF emission from the control unit. An antenna is pivotably connected to the housing. The antenna is movable between 5 a stowed position where RF emission from the antenna is prevented and a deployed position where RF emission from the antenna is permitted. To use the external control unit to effect communication between an external control unit and an implanted medical device, the user places the external control unit within electronic communication range of the implanted medical device. The control unit antenna is 10 moved from the stowed position to a deployed position where RF emission from the antenna is permitted. RF waves are emitted from the antenna to establish communication between the external control unit and the implanted medical device. 13/02/06,eh I5524.spc,2 16 "6 Fz
Patent AU-2006211023-B2 (AU)
Title: Fast wet-massing method for the preparation of calcium-containing compositions
Inventor: BERTELSEN POUL EGON
IPC: A61K9/20
Filed: 2006-02-02
Granted: 2012-05-24
Abstract: The present invention relates to a novel process for the preparation of a granulate comprising a calcium-containing compound as an active substance. The method comprises a method for the preparation of a granulate comprising a calcium-containing compound as an active substance, the method comprising, i) feeding a granulation chamber with a composition comprising the calcium-containing compound, ii) wet-massing the composition with a granulation liquid optionally comprising a pharmaceutically acceptable binder for a time period of at the most 30 sec to obtain a wet granulate, iii) drying the thus obtained wet granulate. A granulate obtained by the present method is especially suitable in the preparation of solid dosage forms, in particular in the preparation of tablets.
Patent AU-2006224619-B2 (AU)
Title: Taste masked dosage form containing roflumilast
Inventor: PONTIUS ALEXANDER
IPC: A61K9/16
Filed: 2006-03-14
Granted: 2012-06-07
Abstract: Taste masked dosage forms for oral administration of roflumilast are described.
Patent AU-2006251754-B2 (AU)
Title: Sling with predictable pre-failure warning indicator
Inventor: GERMAIN DENNIS ST
IPC: B66C1/12
Filed: 2006-05-19
Granted: 2010-06-03
Abstract: A pre-failure warning indicator is provided for use with a sling. The pre-failure warning indicator triggers at a point that is predictable within a relatively narrow range, thereby increasing the possibility that a damaged sling is removed from use. The pre-failure warning indicator includes a dedicated strand of material that is placed in close proximity to the load-bearing core yarns of the sling but remains separate and independent from the core yarns; the ends of the dedicated strand are connected via a sacrificial "ring." A warning fiber having an end that is visible to operators/riggers works in conjunction with the sacrificial strand and the ring. The ring is designed to fail when the sling is subjected to a specifically chosen condition (e.g., excessive weight). The failure of the ring causes the warning fiber to withdraw from the rigger's view thereby warning the rigger that the sling was subjected to the specifically chosen condition and may be damaged.
Patent AU-2006261843-B2 (AU)
Title: Tissue repair
Inventor: SIKORA GEORGE
IPC: A61B17/00
Filed: 2006-06-26
Granted: 2012-11-01
Abstract: A tissue repair device includes a closed knotless loop of multifilament flexible material, and a fixation member having a structure that defines a cavity that receives at least a part of the closed loop. The tissue repair device may include a flexible member traversing the loop. The loop may include a portion in which ends of the multifilament flexible material are thermally fused together. The multifilament flexible material may be braided or twisted.
Patent AU-2006290558-B2 (AU)
Title: Food supplement
Inventor: YATES DEBBY
IPC: A23K1/16
Filed: 2006-09-12
Granted: 2012-07-19
Abstract: The present invention relates to the use of leucine, isoleucine and valine in the manufacture of a food supplement for improving the cognitive ability of a companion animal, a pet food supplement comprising leucine, isoleucine and valine and a method of improving the cognitive ability of an animal especially a companion animal.
Patent AU-2006299221-B2 (AU)
Title: Aerated products with reduced creaming
Inventor: ALDRED DEBORAH LYNNE
IPC: A23L29/269
Filed: 2006-09-13
Granted: 2010-02-18
Abstract: A flowable aerated composition is provided which comprises hydrophobin and a yield stress agent, the composition having a continuous phase viscosity, measured at a shear rate of 10 s−1, of from 0.01 to 2000 Pa s, and a continuous phase apparent yield stress of at least 4 Pa.
Patent AU-2007203118-B2 (AU)
Title: An Extrusion
Inventor: PARKER JEREMY JOSEPH
IPC: E04D3/366
Filed: 2007-07-04
Granted: 2013-04-04
Abstract: Abstract An extrusion for fixing cladding boards to a support structure, said extrusion comprising an external face, a lower board engaging portion, an upper board engaging portion and a projection extending beyond one of the board engaging 5 portions and adapted to allow the extrusion to be attached to said support structure. Figure 1
Patent AU-2007208139-B2 (AU)
Title: 2-substituted benzimidazoles as selective androgen receptor modulators (sarms)
Inventor: NG RAYMOND A
IPC: C07D405/04
Filed: 2007-01-23
Granted: 2012-09-27
Abstract: The present invention is directed to a novel 2-substituted benzimidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
Patent AU-2007209853-B2 (AU)
Title: Divalent metal ion sensors and binders
Inventor: NGWENDSON JULIS N
IPC: G01N21/76
Filed: 2007-01-30
Granted: 2012-07-12
Abstract: Diamino polyacetate benzene compounds are used as a selective fluorescence probe, sensor, or binders for divalent metal ions. The compounds provide for uses as divalent metal ion sensors in diagnostic applications and binders for environmental and medical treatments.
Patent AU-2007211829-B2 (AU)
Title: Domain antibody construct
Inventor: WOOLVEN BENJAMIN P
IPC: A61K39/395
Filed: 2007-02-01
Granted: 2012-11-08
Abstract: The present invention provides a domain antibody construct which binds to human TNF-α, the construct comprising: (a) a domain antibody (dAb) which binds to human TNF-α; (b) a modified hinge region sequence; (c) a human or primate heavy chain constant region sequence having a truncated C1 domain of not more than 20 residues, wherein said modified hinge region sequence contains either a deletion or a single amino acid substitution of at least one cysteine residue which normally facilitates disulfide bond formation between heavy and light antibody chains.
Patent AU-2007215739-B2 (AU)
Title: Biological load indicator and method of measuring biological load
Inventor: SEKIYAMA ATSUO
IPC: G01N33/53
Filed: 2007-02-16
Granted: 2014-01-16
Abstract: It is intended to provide a means whereby various mental or physical conditions such as stress and fatigue, which have been evaluated exclusively depending on subjective symptoms so far, can be objectively and specifically evaluated. More specifically speaking, a stress or fatigue indicator which contains at least two factors selected from the group consisting of IL-1β, IL-1ra, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-11, IL-12, IL-13, IL-15, IL-17, IL-18, Eotaxin, FGF basic, G-CSF, GM-CSF, IFN-γ, IFN-α, IP-10, MCP-1, MIP-1α, MIP-1β, PDGF-BB, RANTES, TNF-α, VEGF, CSF-2, TGF-β, neutrophin 5, MCP-3, β-2-microglobulin, angiotensin II, CSF-3, CXC chemokine ligand 1, CXC chemokine ligand 5 and HGF; an agent for testing stress or fatigue which contains at least two kinds of molecules selected from the group consisting of molecules specifically recognizing the above-described factors respectively; a method of measuring stress or fatigue by using the test agent as described above; and an indicator for evaluating the mental conditions or the severity of a mental disorder which comprises at least two factors selected from the group of the factors as cited above at a weighted composition ratio.
Patent AU-2007286756-B2 (AU)
Title: Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds
Inventor: OLD DAVID W
IPC: A61K31/427
Filed: 2007-08-21
Granted: 2013-10-17
Abstract: A compound having a structure (I) or (II) is disclosed herein. Therapeutic methods, compositions, and medicaments related thereto are also disclosed.
Patent AU-2007300349-B2 (AU)
Title: Wavefront propagation from one plane to another
Inventor: DAI GUANGMING
IPC: A61B3/10
Filed: 2007-08-09
Granted: 2012-07-05
Abstract: The present invention provides methods, systems and software for scaling optical aberration measurements of optical systems. In one embodiment, the present invention provides a method of reconstructing optical tissues of an eye. The method comprises transmitting an image through the optical tissues of the eye. Aberration data from the transmitted image is measured across the optical tissues of the eye at a first plane. A conversion algorithm is applied to the data, converting it to corrective optical power data that can be used as a basis for constructing a treatment for the eye at a second plane.